These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Carboxymethyl mungbean starch as a new pharmaceutical gelling agent for topical preparation. Kittipongpatana OS, Burapadaja S, Kittipongpatana N. Drug Dev Ind Pharm; 2009 Jan; 35(1):34-42. PubMed ID: 18720150 [Abstract] [Full Text] [Related]
3. Development of indomethacin Carbopol ETD 2001 gels and the influence of storage time and temperature on their stability. Shawesh AM, Kaukonen A, Kallioinen S, Antikainen O, Yliruusi J. Pharmazie; 2003 Feb; 58(2):130-5. PubMed ID: 12641331 [Abstract] [Full Text] [Related]
7. Incorporation of small quantities of surfactants as a way to improve the rheological and diffusional behavior of carbopol gels. Barreiro-Iglesias R, Alvarez-Lorenzo C, Concheiro A. J Control Release; 2001 Nov 09; 77(1-2):59-75. PubMed ID: 11689260 [Abstract] [Full Text] [Related]
8. Rheological behavior of gels and meloxicam release. Ruiz Martinez MA, López-Viota Gallardo J, de Benavides MM, de Dios García López-Duran J, Gallardo Lara V. Int J Pharm; 2007 Mar 21; 333(1-2):17-23. PubMed ID: 17056213 [Abstract] [Full Text] [Related]
17. Rheological, adhesive and release characterisation of semisolid Carbopol/tetraglycol systems. Bonacucina G, Cespi M, Misici-Falzi M, Palmieri GF. Int J Pharm; 2006 Jan 13; 307(2):129-40. PubMed ID: 16297581 [Abstract] [Full Text] [Related]
18. In vitro release studies of piroxicam from oil-in-water creams and hydroalcoholic gel topical formulations. Rafiee-Tehrani M, Mehramizi A. Drug Dev Ind Pharm; 2000 Apr 13; 26(4):409-14. PubMed ID: 10769782 [Abstract] [Full Text] [Related]
19. Transbuccal permeation, anti-inflammatory activity and clinical efficacy of piroxicam formulated in different gels. Attia MA, El-Gibaly I, Shaltout SE, Fetih GN. Int J Pharm; 2004 May 19; 276(1-2):11-28. PubMed ID: 15113610 [Abstract] [Full Text] [Related]